Acute Labetalol Use in Preeclampsia

Summary

The purpose of this study is to understand if administration of a personalized dose of the anti-hypertensive medication, labetalol, based on patient's body-mass index, will be more effective at controlling severe hypertension during pregnancy, compared to the current standard dosing.

Timeline

Start

2019-02-18

Primary completion

2020-07-20

Completion

2020-07-20

Outcome

Outcome not reported

Stopped (Enrollment): “Slow enrollment”

Publications

• Results Committee Opinion No. 623: Emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. Obstet Gynecol. 2015 Feb;125(2):521-525. doi: 10.1097/01.AOG.0000460762.59152.d7.

Drugs

Indications